Letter: Grant Funding Chances

Regarding the item entitled "Eye Institute Offers Best Odds For Success" (Funding Briefs, The Scientist, Oct. 30, 1989, page 23), I would like to bring to your attention a crucial omission. The statements regarding award rates are undoubtedly correct; however, they do not note that the award rate percentages include noncompeting continuations. It concerns me that our legislators might read this article and assume that there is a 30% chance of a new grant being funded at NIH. That is particular

Written byJudy Emery
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Regarding the item entitled "Eye Institute Offers Best Odds For Success" (Funding Briefs, The Scientist, Oct. 30, 1989, page 23), I would like to bring to your attention a crucial omission.

The statements regarding award rates are undoubtedly correct; however, they do not note that the award rate percentages include noncompeting continuations. It concerns me that our legislators might read this article and assume that there is a 30% chance of a new grant being funded at NIH. That is particularly worrisome, given the current budget situation, but it would be worrisome even without the current situation.

One of our investigators pointed out this article to me and expressed his concern. I hope that future references to NIH award rates will clarify just what is included in the rate.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery